MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Effectiveness of duodenal levodopa/carbidopa infusion gel (LCIG) therapy on the neuropsychiatric disturbances of advanced Parkinson’s disease (EDIS study)

    M.J. Catalan, P. Montero, J. Herreros, J.M. Arbelo, P. Martinez-Martin (Madrid, Spain)

    Objective: To evaluate the effectiveness of LCIG on neuropsychiatric disturbances in advanced Parkinson's disease (APD) patients. Background: Neuropsychiatric disorders are prevalent in PD and may…
  • 2016 International Congress

    Illusional perception in Parkinson’s disease

    C. Ding, C. Palmer, J. Hohwy, G. Youssef, B. Paton, N. Tsuchiya, J. Stout, D. Thyagarajan (Clayton, Australia)

    Objective: To investigate (a) whether a susceptibility to illusional perceptions is intrinsic to Parkinson's disease even before the onset of hallucinations or cognitive impairment and…
  • 2016 International Congress

    Bradykinesia, low monthly income and current employment are associated with depression in patients with Parkinson’s disease: Results of a study from Sri Lanka

    M.R. Withana, T.B. Herath, C. Rodrigo, C. Gamage, R. Gamage (Colombo, Sri Lanka)

    Objective: The objectives of this cross sectinal studies was to a) estimate the prevalence of depression and b) identify the associations for depression in a…
  • 2016 International Congress

    Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease

    E.J. Vollstedt, K. Hückelheim, S. Tunc, J. Hampf, C. Kritzinger, M. Kasten, C. Klein (Luebeck, Germany)

    Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…
  • 2016 International Congress

    Personality and addictive behaviours in prodromal and early Parkinson’s disease

    F. BaigBM, M. Lawton, M. Rolinski, C. Ruffmann, J. Klein, K. Nithi, D. Okai, Y. Ben-Shlomo, M.T.M. Hu (Oxford, United Kingdom)

    Objective: To determine whether the personality changes demonstrated in established Parkinson's disease (PD) are found in the earliest stages of PD and the prodromal stage.…
  • 2016 International Congress

    Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease

    M. Picillo, G. Santangelo, R. Erro, A. Cozzolino, M. Amboni, C. Vitale, P. Barone, M.T. Pellecchia (Baronissi, Italy)

    Objective: To explore the relationships between nigrostriatal dysfunction and both neuropsychiatric (including anxiety, depression and apathy) and cognitive symptoms in newly diagnosed, drug-naive Parkinson's disease…
  • 2016 International Congress

    Parkinson’s disease associated psychosis: Prevalence and risk factors

    A. Dutt, H. Kumar, M. Mukherjee, M.U. Kulsum, C. Sengupta (Kolkata, India)

    Objective: To compare prevalence of psychosis in Parkinson's disease (PD) using the NINDS-NIMH and standard criteria (hallucinations and / or delusions). Background: The prevalence of…
  • 2016 International Congress

    The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease

    M.M. Dumitru (Iasi, Romania)

    Objective: The objective of this study was to assess the frequency of suicidal ideation and suicide attempts in a sample of consecutive patients with Parkinson's…
  • 2016 International Congress

    Relation between personality trait and depression in Parkinson’s disease

    A. Kumon, Y. Kobayashi, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

    Objective: 1. To investigate personality trait of patients with Parkinson's disease (PD). 2. To clarify the relationship between personality trait and depression in patients with…
  • 2016 International Congress

    Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings

    D.L. McCabe, A.D. Bono, R.J. Stafford, A.I. Dumer, K.A. Scorpio, J.L. Spielman, R. Bind, L.O. Ramig, J.C. Borod (New York, NY, USA)

    Objective: The purpose was to examine facial emotional expression in individuals with PD and in healthy control (HC) subjects (Ss) using the Facial Action Coding…
  • « Previous Page
  • 1
  • …
  • 1489
  • 1490
  • 1491
  • 1492
  • 1493
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley